Zobrazeno 1 - 10
of 353
pro vyhledávání: '"Margaret V, Ragni"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundAlmost half of severe hemophilia A (HA) is caused by an intron 22 inversion mutation (Int22Inv), which disrupts the 26-exon F8 gene. Inverted F8 mRNA exons 1-22 are transcribed, while F8B mRNA, containing F8 exons 23-26, is transcribed from
Externí odkaz:
https://doaj.org/article/0cf650a9b8034b0ca520dab1173bb4ca
Autor:
Pratima Chowdary, Margareta Holmström, Johnny N. Mahlangu, Margaret C. Ozelo, Ingrid Pabinger, K. John Pasi, Margaret V. Ragni, Amy Shapiro, Chris Barnowski, Stefan Lethagen
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)
Abstract Background Surgical procedures impose hemostatic risk to people with hemophilia, which may be minimized by optimal factor (F) replacement therapy. Methods This analysis evaluates the efficacy and safety of extended half‐life factor replace
Externí odkaz:
https://doaj.org/article/27d90e491f2146ce8178fc257538ffa6
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 3, Pp 1061-1072 (2021)
Chronic liver disease is one of the leading causes of death in the United States. Coagulopathy is often a sequela of chronic liver disease, however, the role and regulation of coagulation components in chronic liver injury remain poorly understood. C
Externí odkaz:
https://doaj.org/article/00a9ecfb64a345c989b7cb8b567d7e9e
Publikováno v:
Pilot and Feasibility Studies, Vol 6, Iss 1, Pp 1-8 (2020)
Abstract Background Acute chest syndrome (ACS) is the leading cause of mortality in sickle cell disease (SCD). The pathogenesis of ACS is complex and not entirely understood with multiple etiologies likely contributing simultaneously. One particular
Externí odkaz:
https://doaj.org/article/61e99cf7b0074eb686a42759b3280bc0
Autor:
Margaret V. Ragni, Elaine Majerus, Sylvia Fong, Bridget Yates, Stephen Scheeler, Lisa Razon, Hua Yu, Divya B. Reddy, Tara M. Robinson
Publikováno v:
Blood Advances. 7:1525-1530
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ed0bda2d4709dc8eaed3d4d00252a8a
https://doi.org/10.1182/bloodadvances.2022008948
https://doi.org/10.1182/bloodadvances.2022008948
Autor:
Margaret V. Ragni, Guy Young, Glaivy Batsuli, Emily Bisson, Shannon L. Carpenter, Stacy E. Croteau, Adam Cuker, Randall G. Curtis, Michael Denne, Bruce Ewenstein, Amber Federizo, Neil Frick, Kerry Funkhouser, Lindsey A. George, W. Keith Hoots, Shawn M. Jobe, Emily Krava, Christopher James Langmead, Roger J. Lewis, José López, Lynn Malec, Ziva Mann, Moses E. Miles, Emma Neely, Ellis J. Neufeld, Glenn F. Pierce, Steven W. Pipe, Lisa R. Pitler, Leslie Raffini, Kathaleen M. Schnur, Jordan A. Shavit
Publikováno v:
Expert Review of Hematology. 16:107-127
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60465e8fcb91f7f8234e18e9dbcab6f8
https://doi.org/10.1080/17474086.2023.2181781
https://doi.org/10.1080/17474086.2023.2181781
Publikováno v:
TH Open, Vol 04, Iss 01, Pp e51-e58 (2020)
Introduction Thrombosis is more common in inflammatory bowel disease (IBD) patients than the general population, but disease-specific correlates of thrombosis remain unclear. Methods We performed a retrospective analysis of discharge data from the Na
Externí odkaz:
https://doaj.org/article/a9181937c0f54ac39ce5e854281d21f5
Publikováno v:
Blood Advances, Vol 2, Iss 14, Pp 1792-1798 (2018)
Abstract: Gene therapy provides a potential phenotypic cure for hemophilia, yet the cost of this novel treatment is high, tempering enthusiasm and raising questions regarding cost vs benefit. To evaluate the cost-effectiveness of gene therapy treatme
Externí odkaz:
https://doaj.org/article/47aa3357577f45dea0949627cdc872da
Autor:
Margaret V. Ragni
Publikováno v:
Blood Advances, Vol 1, Iss 11, Pp 703-706 (2017)
Externí odkaz:
https://doaj.org/article/5f363d8f26f347dda296d1ff3a882ccb
Autor:
Tomasz W. Kaminski, Eun-Mi Ju, Shweta Gudapati, Ravi Vats, Sanya Arshad, Rikesh K. Dubey, Omika Katoch, Egemen Tutuncuoglu, Jonathan Frank, Tomasz Brzoska, Donna B. Stolz, Simon C. Watkins, Stephen Y. Chan, Margaret V. Ragni, Enrico M. Novelli, Prithu Sundd, Tirthadipa Pradhan-Sundd
Publikováno v:
Blood Advances. 6:3729-3734
Hemophilia A is an inherited bleeding disorder caused by defective or deficient coagulation factor VIII (FVIII) activity. Until recently, the only treatment for prevention of bleeding involved IV administration of FVIII. Gene therapy with adeno-assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60cc4e3a6b450a485ecb24a3b24260d8
https://doi.org/10.1182/bloodadvances.2021006388
https://doi.org/10.1182/bloodadvances.2021006388